Hersintuzumab (Anti-ERBB2 / HER2 / CD340)
Hersintuzumab (Anti-ERBB2 / HER2 / CD340) is a humanized monoclonal antibody that targets human epidermal growth factor receptor 2 (HER2), extracellular domains I–II, with antitumor activity in ovarian cancer. MW: 144.26 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2898 |
Sku # | A2898-1mg*25 |
Pricing | 1mg*25, $5070.00 |